Lymphatic Drainage of the Breast, a Retrospective Assessment of Data

September 21, 2021 updated by: Dr. Elisabeth Würinger
retrospective evaluation of patients, in whom blue colour was injected into different sites of the breast before breast reduction, to investigate direction and localisation of lymphatic flow. Investigations were performed at the Wilhelminenspital, Vienna, in the years 1998 to 2009.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

14

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Austria
    • Österreich
      • Wien, Österreich, Austria, 1130
        • Elisabeth Wuringer

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

Female

Sampling Method

Probability Sample

Study Population

Patients, who were operated on breast reduction

Description

Inclusion Criteria: Patients, who understood and supported the aim of the study and signed the written consent -

Exclusion Criteria: language barriers, patients, who did not understand and support the aim of the study

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
injection behind NAC
in 7 breasts dye was injected behind the nipple areola complex before breast reduction
Procedure: anatomical examination
After injection of dye, its distribution along lymphatic clearance paths was investigated
Injection into lateral upper quadrant
in 5 breasts dye was injected into upper lateral glandular tissue before breast reduction
Procedure: anatomical examination
After injection of dye, its distribution along lymphatic clearance paths was investigated
injection into medial upper quadrant
in 2 breasts dye was injected into upper medial glandular tissue before breast reduction
Procedure: anatomical examination
After injection of dye, its distribution along lymphatic clearance paths was investigated

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Lymphatic flow is guided by the ligamentous suspension
Time Frame: The ligamentous suspension (horizontal septum, vertical ligaments merging into superficial fascia) is exposed in the course of breast reduction in the technique, that I described usually within about 40 minutes
colour gathered along horizontal septum
The ligamentous suspension (horizontal septum, vertical ligaments merging into superficial fascia) is exposed in the course of breast reduction in the technique, that I described usually within about 40 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Dr. Elisabeth Würinger

Investigators

  • Principal Investigator: Elisabeth Würinger, Dr. Elisabeth Würinger

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 25, 2021

Primary Completion (Actual)

July 10, 2021

Study Completion (Actual)

August 10, 2021

Study Registration Dates

First Submitted

August 24, 2021

First Submitted That Met QC Criteria

September 21, 2021

First Posted (Actual)

October 1, 2021

Study Record Updates

Last Update Posted (Actual)

October 1, 2021

Last Update Submitted That Met QC Criteria

September 21, 2021

Last Verified

September 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • EK 21-102-VK

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Lymph Drainage of Breast

Clinical Trials on anatomical examination

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kuwait

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe